ANI Pharmaceuticals, Inc. (ANIP) has a consensus analyst rating of Buy, based on 10 analysts covering the stock. Of those, 7 recommend buying, 3 recommend holding, and 0 recommend selling.
The analyst consensus price target for ANIP is $107.00, representing a +36.7% upside from the current price of $78.29. Price targets range from a low of $90.00 to a high of $124.00.
